Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
RECRUITING
NCT07816692
iDose TR Administration in an Office-Based Surgery Setting
Sponsor: Glaukos Corporation
View on ClinicalTrials.gov
Summary
Clinical in-use observational trial to evaluate the administration of iDose TR (travoprost intracameral implant) in an office-based surgery setting.
Official title: Real-World Evidence Observational Study to Evaluate the Safety of iDose® TR (Travoprost Intracameral Implant) 75 µg in an Office-Based Surgery Setting
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
30
Start Date
2026-05-13
Completion Date
2027-03
Last Updated
2026-09-14
Healthy Volunteers
No
Interventions
COMBINATION_PRODUCT
iDose TR (travoprost intracameral implant) 75 µg
Travoprost-releasing implant preloaded in a sterile, single-use inserter.
Locations (1)
Glaukos Investigative Site
Austin, Texas, United States